Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Zhonggui Pharmaceutical is a Chinese pharmaceutical company headquartered in Mudanjiang, Heilongjiang Province. Founded in 2004, the firm specializes in the development and large-scale manufacturing of chemical pharmaceuticals and traditional Chinese medicine (TCM) preparations. Its product portfolio includes a variety of dosage forms such as capsules, tablets, and granules, with a strong presence in the over-the-counter (OTC) market for respiratory and cardiovascular health. The company operates modern, GMP-compliant production lines to ensure the quality of its widely distributed generic medications. Key products include compound paracetamol and amantadine hydrochloride capsules for cold relief and ginkgo biloba extracts for circulatory health. Heilongjiang Zhonggui Pharmaceutical remains a significant contributor to the regional life sciences industry in Northeast China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Zhonggui Pharmaceutical.